Eli Lilly and Company (LLY)
USD 824.06
(-0.69%)
USD 824.06
(-0.69%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 53.14 Billion USD | 37.27% |
| 2022 | 38.71 Billion USD | -2.36% |
| 2021 | 39.65 Billion USD | -2.83% |
| 2020 | 40.8 Billion USD | 11.54% |
| 2019 | 36.58 Billion USD | 10.87% |
| 2018 | 32.99 Billion USD | -0.94% |
| 2017 | 33.31 Billion USD | 34.73% |
| 2016 | 24.72 Billion USD | 17.86% |
| 2015 | 20.97 Billion USD | -3.72% |
| 2014 | 21.79 Billion USD | 23.75% |
| 2013 | 17.6 Billion USD | -10.28% |
| 2012 | 19.62 Billion USD | -2.48% |
| 2011 | 20.12 Billion USD | 8.26% |
| 2010 | 18.58 Billion USD | 3.64% |
| 2009 | 17.93 Billion USD | -20.21% |
| 2008 | 22.47 Billion USD | 71.28% |
| 2007 | 13.12 Billion USD | 19.58% |
| 2006 | 10.97 Billion USD | -20.41% |
| 2005 | 13.78 Billion USD | -1.13% |
| 2004 | 13.94 Billion USD | 17.07% |
| 2003 | 11.91 Billion USD | 10.63% |
| 2002 | 10.76 Billion USD | 15.42% |
| 2001 | 9.33 Billion USD | 7.94% |
| 2000 | 8.64 Billion USD | 10.65% |
| 1999 | 7.81 Billion USD | -4.33% |
| 1998 | 8.16 Billion USD | 5.07% |
| 1997 | 7.77 Billion USD | -5.3% |
| 1996 | 8.2 Billion USD | -8.61% |
| 1995 | 8.97 Billion USD | -1.88% |
| 1994 | 9.15 Billion USD | 81.05% |
| 1993 | 5.05 Billion USD | 33.7% |
| 1992 | 3.78 Billion USD | 13.45% |
| 1991 | 3.33 Billion USD | -9.33% |
| 1990 | 3.67 Billion USD | 75.78% |
| 1989 | 2.09 Billion USD | 2.63% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 58.23 Billion USD | 14.09% |
| 2024 Q1 | 51.04 Billion USD | -3.95% |
| 2024 Q3 | 61.28 Billion USD | 5.23% |
| 2023 Q4 | 53.14 Billion USD | 14.02% |
| 2023 FY | 53.14 Billion USD | 37.27% |
| 2023 Q1 | 41.86 Billion USD | 8.15% |
| 2023 Q2 | 43.66 Billion USD | 4.29% |
| 2023 Q3 | 46.6 Billion USD | 6.74% |
| 2022 Q4 | 38.71 Billion USD | 3.8% |
| 2022 Q2 | 38.4 Billion USD | 2.53% |
| 2022 FY | 38.71 Billion USD | -2.36% |
| 2022 Q3 | 37.29 Billion USD | -2.89% |
| 2022 Q1 | 37.45 Billion USD | -5.53% |
| 2021 FY | 39.65 Billion USD | -2.83% |
| 2021 Q4 | 39.65 Billion USD | -1.45% |
| 2021 Q3 | 40.23 Billion USD | -2.22% |
| 2021 Q2 | 41.14 Billion USD | 3.54% |
| 2021 Q1 | 39.73 Billion USD | -2.62% |
| 2020 Q3 | 38.95 Billion USD | 3.33% |
| 2020 FY | 40.8 Billion USD | 11.54% |
| 2020 Q2 | 37.69 Billion USD | -0.56% |
| 2020 Q1 | 37.9 Billion USD | 3.6% |
| 2020 Q4 | 40.8 Billion USD | 4.77% |
| 2019 Q4 | 36.58 Billion USD | 6.26% |
| 2019 Q2 | 35.8 Billion USD | 1.04% |
| 2019 Q1 | 35.44 Billion USD | 7.4% |
| 2019 FY | 36.58 Billion USD | 10.87% |
| 2019 Q3 | 34.43 Billion USD | -3.85% |
| 2018 Q2 | 30.73 Billion USD | 3.26% |
| 2018 Q3 | 30.47 Billion USD | -0.86% |
| 2018 FY | 32.99 Billion USD | -0.94% |
| 2018 Q1 | 29.76 Billion USD | -10.64% |
| 2018 Q4 | 32.99 Billion USD | 8.29% |
| 2017 Q3 | 28.04 Billion USD | 4.75% |
| 2017 Q1 | 23.52 Billion USD | -4.87% |
| 2017 Q4 | 33.31 Billion USD | 18.76% |
| 2017 FY | 33.31 Billion USD | 34.73% |
| 2017 Q2 | 26.77 Billion USD | 13.84% |
| 2016 Q1 | 19.66 Billion USD | -6.27% |
| 2016 FY | 24.72 Billion USD | 17.86% |
| 2016 Q3 | 21.97 Billion USD | 0.71% |
| 2016 Q4 | 24.72 Billion USD | 12.52% |
| 2016 Q2 | 21.81 Billion USD | 10.97% |
| 2015 Q3 | 21.06 Billion USD | -1.25% |
| 2015 Q1 | 20.7 Billion USD | -4.97% |
| 2015 FY | 20.97 Billion USD | -3.72% |
| 2015 Q4 | 20.97 Billion USD | -0.4% |
| 2015 Q2 | 21.33 Billion USD | 3.01% |
| 2014 Q3 | 16.96 Billion USD | -0.34% |
| 2014 FY | 21.79 Billion USD | 23.75% |
| 2014 Q1 | 16.4 Billion USD | -6.81% |
| 2014 Q2 | 17.02 Billion USD | 3.75% |
| 2014 Q4 | 21.79 Billion USD | 28.43% |
| 2013 Q2 | 17.98 Billion USD | 3.72% |
| 2013 Q4 | 17.6 Billion USD | 3.15% |
| 2013 FY | 17.6 Billion USD | -10.28% |
| 2013 Q1 | 17.34 Billion USD | -11.62% |
| 2013 Q3 | 17.06 Billion USD | -5.11% |
| 2012 Q2 | 17.5 Billion USD | 0.51% |
| 2012 Q3 | 18.26 Billion USD | 4.34% |
| 2012 Q4 | 19.62 Billion USD | 7.45% |
| 2012 FY | 19.62 Billion USD | -2.48% |
| 2012 Q1 | 17.41 Billion USD | -13.46% |
| 2011 Q2 | 18.5 Billion USD | 4.17% |
| 2011 Q3 | 17.98 Billion USD | -2.8% |
| 2011 Q4 | 20.12 Billion USD | 11.9% |
| 2011 FY | 20.12 Billion USD | 8.26% |
| 2011 Q1 | 17.76 Billion USD | -4.45% |
| 2010 Q1 | 16.73 Billion USD | -6.69% |
| 2010 FY | 18.58 Billion USD | 3.64% |
| 2010 Q2 | 17.48 Billion USD | 4.5% |
| 2010 Q3 | 17.49 Billion USD | 0.02% |
| 2010 Q4 | 18.58 Billion USD | 6.28% |
| 2009 FY | 17.93 Billion USD | -20.21% |
| 2009 Q4 | 17.93 Billion USD | 4.14% |
| 2009 Q3 | 17.22 Billion USD | -6.25% |
| 2009 Q2 | 18.37 Billion USD | -2.65% |
| 2009 Q1 | 18.87 Billion USD | -16.04% |
| 2008 Q3 | 13.96 Billion USD | 7.31% |
| 2008 Q4 | 22.47 Billion USD | 60.95% |
| 2008 FY | 22.47 Billion USD | 71.28% |
| 2008 Q1 | 12.31 Billion USD | -6.2% |
| 2008 Q2 | 13.01 Billion USD | 5.72% |
| 2007 Q2 | 12.49 Billion USD | 2.43% |
| 2007 Q1 | 12.19 Billion USD | 11.16% |
| 2007 Q4 | 13.12 Billion USD | 9.12% |
| 2007 FY | 13.12 Billion USD | 19.58% |
| 2007 Q3 | 12.02 Billion USD | -3.75% |
| 2006 FY | 10.97 Billion USD | -20.41% |
| 2006 Q4 | 10.97 Billion USD | 1.07% |
| 2006 Q3 | 10.85 Billion USD | -13.18% |
| 2006 Q2 | 12.5 Billion USD | 0.44% |
| 2006 Q1 | 12.45 Billion USD | -9.69% |
| 2005 Q4 | 13.78 Billion USD | 2.75% |
| 2005 Q3 | 13.42 Billion USD | 2.05% |
| 2005 Q2 | 13.15 Billion USD | 12.96% |
| 2005 Q1 | 11.64 Billion USD | -16.53% |
| 2005 FY | 13.78 Billion USD | -1.13% |
| 2004 Q3 | 12.87 Billion USD | 4.92% |
| 2004 Q1 | 11.84 Billion USD | -0.58% |
| 2004 Q2 | 12.27 Billion USD | 3.62% |
| 2004 Q4 | 13.94 Billion USD | 8.32% |
| 2004 FY | 13.94 Billion USD | 17.07% |
| 2003 Q4 | 11.91 Billion USD | 5.28% |
| 2003 FY | 11.91 Billion USD | 10.63% |
| 2003 Q1 | 10.91 Billion USD | 1.35% |
| 2003 Q2 | 11.36 Billion USD | 4.13% |
| 2003 Q3 | 11.31 Billion USD | -0.43% |
| 2002 Q2 | 9.79 Billion USD | 4.68% |
| 2002 Q4 | 10.76 Billion USD | 1.03% |
| 2002 Q1 | 9.35 Billion USD | 0.31% |
| 2002 FY | 10.76 Billion USD | 15.42% |
| 2002 Q3 | 10.65 Billion USD | 8.79% |
| 2001 Q4 | 9.33 Billion USD | 3.32% |
| 2001 FY | 9.33 Billion USD | 7.94% |
| 2001 Q3 | 9.03 Billion USD | 1.81% |
| 2001 Q2 | 8.87 Billion USD | 8.72% |
| 2001 Q1 | 8.15 Billion USD | -5.61% |
| 2000 FY | 8.64 Billion USD | 10.65% |
| 2000 Q1 | 7.03 Billion USD | -9.94% |
| 2000 Q2 | 7.51 Billion USD | 6.83% |
| 2000 Q3 | 7.52 Billion USD | 0.06% |
| 2000 Q4 | 8.64 Billion USD | 14.93% |
| 1999 Q4 | 7.81 Billion USD | 4.66% |
| 1999 Q3 | 7.46 Billion USD | 17.19% |
| 1999 Q2 | 6.36 Billion USD | 0.06% |
| 1999 Q1 | 6.36 Billion USD | -22.05% |
| 1999 FY | 7.81 Billion USD | -4.33% |
| 1998 Q1 | 7.09 Billion USD | -8.73% |
| 1998 FY | 8.16 Billion USD | 5.07% |
| 1998 Q4 | 8.16 Billion USD | 3.21% |
| 1998 Q3 | 7.91 Billion USD | 11.96% |
| 1998 Q2 | 7.06 Billion USD | -0.37% |
| 1997 Q3 | 7.42 Billion USD | -2.5% |
| 1997 Q1 | 7.94 Billion USD | -3.2% |
| 1997 Q2 | 7.61 Billion USD | -4.09% |
| 1997 FY | 7.77 Billion USD | -5.3% |
| 1997 Q4 | 7.77 Billion USD | 4.62% |
| 1996 Q1 | 8.31 Billion USD | -7.41% |
| 1996 Q3 | 8.02 Billion USD | -4.05% |
| 1996 Q4 | 8.2 Billion USD | 2.26% |
| 1996 FY | 8.2 Billion USD | -8.61% |
| 1996 Q2 | 8.36 Billion USD | 0.6% |
| 1995 Q4 | 8.97 Billion USD | 2.45% |
| 1995 Q1 | 9.12 Billion USD | -0.29% |
| 1995 FY | 8.97 Billion USD | -1.88% |
| 1995 Q2 | 9.12 Billion USD | -0.02% |
| 1995 Q3 | 8.76 Billion USD | -3.93% |
| 1994 Q3 | 5.19 Billion USD | 3.28% |
| 1994 Q4 | 9.15 Billion USD | 76.23% |
| 1994 Q1 | 4.86 Billion USD | -3.69% |
| 1994 FY | 9.15 Billion USD | 81.05% |
| 1994 Q2 | 5.02 Billion USD | 3.29% |
| 1993 Q2 | 3.74 Billion USD | -2.34% |
| 1993 Q3 | 3.85 Billion USD | 2.94% |
| 1993 Q4 | 5.05 Billion USD | 31.15% |
| 1993 FY | 5.05 Billion USD | 33.7% |
| 1993 Q1 | 3.83 Billion USD | 1.41% |
| 1992 FY | 3.78 Billion USD | 13.45% |
| 1992 Q1 | 3.11 Billion USD | -6.55% |
| 1992 Q2 | 3.21 Billion USD | 3.08% |
| 1992 Q3 | 3.7 Billion USD | 15.29% |
| 1992 Q4 | 3.78 Billion USD | 2.15% |
| 1991 Q2 | 2.71 Billion USD | 4.14% |
| 1991 Q4 | 3.33 Billion USD | 10.29% |
| 1991 Q3 | 3.02 Billion USD | 11.34% |
| 1991 Q1 | 2.6 Billion USD | -29.09% |
| 1991 FY | 3.33 Billion USD | -9.33% |
| 1990 Q2 | 2.48 Billion USD | 24.18% |
| 1990 Q3 | 3.28 Billion USD | 31.9% |
| 1990 Q4 | 3.67 Billion USD | 11.92% |
| 1990 FY | 3.67 Billion USD | 75.78% |
| 1990 Q1 | 2 Billion USD | -4.11% |
| 1989 Q3 | 1.95 Billion USD | 5.56% |
| 1989 FY | 2.09 Billion USD | 2.63% |
| 1989 Q4 | 2.09 Billion USD | 6.91% |
| 1989 Q2 | 1.85 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbbVie Inc. | 124.31 Billion USD | 57.251% |
| Bristol-Myers Squibb Company | 65.67 Billion USD | 19.081% |
| Bristol-Myers Squibb Company Ce | 65.67 Billion USD | 19.081% |
| Johnson & Johnson | 98.78 Billion USD | 46.203% |
| Merck & Co., Inc. | 69.04 Billion USD | 23.026% |
| Novartis AG | 53.19 Billion USD | 0.099% |
| Organon & Co. | 12.12 Billion USD | -338.181% |
| Pfizer Inc. | 137.21 Billion USD | 61.27% |